Rabbit anti-FAF2/ETEA Antibody Affinity Purified
Product Details
Specifications
The epitope recognized by A305-379A maps to a region between residue 395 to 445 of human FAS-associated factor 2 using the numbering given in entry Q96CS3.2 (GeneID 23197).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4. Antibody was affinity purified using an epitope specific to FAF2/ETEA immobilized on solid support.
The epitope recognized by A305-379A-T maps to a region between residue 395 to 445 of human FAS-associated factor 2 using the numbering given in entry Q96CS3.2 (GeneID 23197).
Additional Product Information
FAF2/ETEA is highly expressed in peripheral blood of patients with atopic dermatitis (AD), compared to normal individuals. It may play a role in regulating the resistance to apoptosis that is observed in T cells and eosinophils of AD patients [taken from NCBI Entrez Gene (Gene ID: 23197)].
Alternate Names
ETEA; expressed in T-cells and eosinophils in atopic dermatitis; FAS-associated factor 2; Protein ETEA; UBX domain containing 8; UBX domain protein 3B; UBX domain-containing protein 3B; UBX domain-containing protein 8; UBXD8; UBXN3B
Applications
All western blot analysis is performed using 5% Milk-TBST for blocking and as antibody diluent. Primary antibody is incubated overnight.
Western blots of cell lysates are performed using Goat anti-Rabbit IgG Heavy and Light Chain Antibody (Cat. No. A120-101P).
Western blots of immunoprecipitates are performed using Goat anti-Rabbit Light Chain HRP Conjugate (Cat. No. A120-113P) with 5% Normal Pig Serum (Cat. No. S100-020) added to the blocking buffer.